Butyrophilins Role in Colon Cancer

Recruiting N/A Interventional Study
Colonic Cancer
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Basic Science
Participants needed
200 (estimated)
Sponsor
Institut Paoli-Calmettes · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

quantification of BTNL molecules in colon cancer in order to determinate if their could be used as a prognostic marquer

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patient is older than 18 years old, * Signed participation consent, * Non-metastatic colon cancer immediately resectable or metastatic and liver synchronous for which it was decided a combined colic and liver surgery (metastatic patient at the outset) in multidisciplinary cons…
Contacts

Jihane PAKRADOUNI, PharmD,PhD

04 91 22 37 78

drci.up@ipc.unicancer.fr

CONTACT

Laurie-Anne GOUTY, PhD

33491223778

drci.up@ipc.unicancer.fr

CONTACT